Thank you for submitting your manuscript for consideration by The EMBO Journal. I have now received the final report from the two referees who evaluated your study and I enclose their comments below. As you will see from these comments overall they find the insight gained into the subcellular localization of tasi-RNA components and processing to be interesting and important. I have also had an opportunity to discuss in the referee reports with the referees. Referee #2 raises a number of concerns including that the current study does not definitively demonstrate that localization of AGO7 to membranes is important for its function or how AGO7 associates with these membranes or siRNA bodies. These experiments would clearly enhance the study but at this time it is not clear if there are conditions where the specific targeting of AGO7 to membrane could be disrupted. We therefore suggest that if you have data that would strengthen the study along these lines it should be included but it is not absolutely required for publication. The more minor technical issues should be addressed in full. Based on the interest form the referees and should you be able to satisfactorily address these issues I would like to invite you to submit a revised version of the manuscript.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript. When you submit a revised version to the EMBO Journal, please make sure you upload a letter of response to the referees' comments. Please note that when preparing your letter of response to the referees' comments that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal
REFEREE REPORTS

Referee #1
This manuscript shows evidence that Arabidopsis AGO7 localizes in distinct cytoplasmic granules under normal conditions, and into stress granules upon heat-shock. This localization is consistent with the identical, previously described, localization patterns of RDR6 and SGS3, two other proteins required for trans-acting siRNA biogenesis in plants. Biochemical fractionation provides robust evidence to support a membrane association of AGO7. Most interestingly, strong evidence is presented that indicates the sub-cellular localization of AGO7 is critical for its function. Overall, this study provides convincing evidence showing that trans-acting siRNA and other secondary siRNAs are made in a discrete, membrane-associate cytoplasmic domain that coincides with heat-stress granules.
The study is well-conducted and appropriate conlcusions are drawn from the data. The writing and figures are very clear. I believe the paper will be of broad interest and I have only a few minor comments / suggestions for the authors:
1. Figure S1B appears to show a key experiment .. native promoter HA-AGO7 also goes to foci. Why not move this to main text? The native promoter experiment is key to show that the other results are not artifacts of over-expression. Similar comments for Figure S7 , which shows lack of complementation of the zippy phenotype by a nuclear-targeted AGO7 when driven by the native promoter.
2. Figure 5 's legend title is not accurate. No tasi-ARF data are shown in the figure. 3. Figure 6D : The key control for this blot, the zip-1 lane, appears to be from a different filter. If so, it can't be relied upon in this experiment. The authors should clarify if the image cropping has just removed irrelevant sections from the same hybridization experiment, or re-do the analysis including all required controls on the same filter.
Referee #2
Jouannet et al. examined the subcellular localization of AGO7, an argonaute protein required for the biogenesis of trans-acting siRNAs targeting several ARF genes (also known as tasiR-ARFs). They report co-localization of AGO7 with SGS3 and RDR6, two proteins that have previously been shown to be required for tasiR-ARF biogenesis and to localize in cytoplasmic foci termed siRNA bodies. An intriguing finding from this study is that these siRNA bodies are close to membranes and AGO7 is in the membrane-rich microsomal fraction. They also showed that forcing AGO7 to localize to the nucleus compromises its function in tasiR-ARF biogenesis.
A major contribution of this study is linking AGO7 with membranes. However, the study did not show that this membrane association is important for the functions of AGO7 in tasiRNA biogenesis. The data showing that nuclear localization of AGO7 compromises its activity are not sufficient to show that membrane association or siRNA body association is necessary for its function. Because of this, the title of the manuscript is not justified. It would be ideal to retain cytoplasmic localization of AGO7 and abolish only siRNA body localization of AGO7 to address this issue. Another major unanswered question is how AGO7 becomes associated with membranes or siRNA bodies. Obvious experiments that were not performed include testing whether AGO7 localization to siRNA bodies or membranes occurs in rdr6 or sgs3 mutants, whether AGO7 interacts with SGS3 or RDR6, or whether AGO7 localization requires miR390 (the miRNA that AGO7 specifically associates with). miR390 was found to be enriched in the microsomal fraction in the presence or absence of its binding partner AGO7. The observation is interesting but raises more questions without answers at present.
Other issues:
1. The immunolocalization with anti-HA on AGO7p::HA-AGO7 is very important for the conclusion that AGO7 localizes to cytoplasmic granules. But the experiment lacks a negative control (immunolocalization with the same antibodies on wild-type plants).
2. To my knowledge, most microsomal membranes are completely solubilized by 1% triton, but AGO7 is still in the pellet after 1% triton treatment. This suggests to me that instead of being membrane associated, AGO7 is associated with large, non-membrane structures such as the cytoskeleton. Another point related to this assay is that they did not provide details regarding how much material from S100 and P100 was used in the western blot. As we know, the volume of S100 would far exceed that of P100. Without knowing the relative amounts of material used in the western, it is hard for the reader to judge how much enrichment there is in the P100 fraction.
3. The title of Figure 5 claims that miR390 and tasiR-ARFs co-fractionate with AGO7, but only data on miR390 were shown. Response to Referee #1: Figure S7 , which shows lack of complementation of the zippy phenotype by a nuclear-targeted AGO7 when driven by the native promoter.
Figure S1B appears to show a key experiment .. native promoter HA-AGO7 also goes to foci. Why not move this to main text? The native promoter experiment is key to show that the other results are not artifacts of over-expression. Similar comments for
> We agree with the reviewer, these two pieces of data are key and should be part of the main figures. In the revised version, we have moved these figures to panels 1G and 6E of Figure 1 and 6 respectively.
Figure 5's legend title is not accurate. No tasi-ARF data are shown in the figure.
> We apologize to the reviewer for this mistake. The title has been updated.
3. Figure 6D > The zip-1 mutant lane is on the same filter as the NLS-HA-AGO7 and (NES+NLS)-HA-AGO7 samples. However, when mounting the figure, we cut out 3 lanes corresponding to another AGO7 variant that revealed uninformative. The uncropped blot showing these extra lanes is enclosed. In addition, and thanks to the reviewer comment, we spotted a typo in the ta-siRNA/U6 ratio for the zip-1 mutant: 0.11 is the correct ratio not 0.05 as it was displayed previously in the figure. We updated the Figure 6D accordingly.
Response to Referee #2:
A > We agree with the reviewer. In absence of a mutant impairing only siRNA bodies targeting, we have no definitive proof that it is in these bodies that AGO7 acts. To more accurately reflects this, we have changed the title to "Cytoplasmic Arabidopsis AGO7 accumulates in membrane-associated siRNA bodies and is required for tasiRNA biogenesis" and amended the discussion accordingly.
Another major unanswered question is how AGO7 becomes associated with membranes or siRNA bodies. Obvious experiments that were not performed include testing whether AGO7 localization to siRNA bodies or membranes occurs in rdr6 or sgs3 mutants
> The experiment suggested by the reviewer has been performed. We have monitored the levels of HA-AGO7 in the P100 fraction in sgs3 (sgs3-1) or rdr6 (sgs2-1) mutants. Compared to wild type, we did not observe any difference in AGO7 accumulation. This suggests that neither SGS3 nor RDR6 are required for targeting AGO7 to the membrane. We have included these data as a supplemental figure ( Figure S7 ) and expanded the discussion accordingly.
or whether AGO7 localization requires miR390 (the miRNA that AGO7 specifically associates with). miR390 was found to be enriched in the microsomal fraction in the presence or absence of its binding partner AGO7. The observation is interesting but raises more questions without answers at present.
> We agree with the reviewer that testing the role of miR390 in targeting AGO7 to siRNA bodies or membranes is important. In absence of a mir390a/mir390b double mutant and as the available miR390 mimic lines do not display the expected zippy phenotype, suggesting that residual miR390 activity remain, such an analysis is difficult to perform. However, as only the MIR390A precursor is expressed in the roots, we have attempted to look at AGO7 membrane association in the roots of a mir390a mutant. Despite the very low levels of expression of AGO7 in this tissue, we still observe association of AGO7 in the P100 fraction ( Figure S7 ). This suggests that miR390 is not required for targeting AGO7 to the membrane.
The immunolocalization with anti-HA on AGO7p::HA-AGO7 is very important for the conclusion that AGO7 localizes to cytoplasmic granules. But the experiment lacks a negative control (immunolocalization with the same antibodies on wild-type plants).
> The control has been included as an inset and these datas moved from Figure S1 to Figure 1G .
To my knowledge, most microsomal membranes are completely solubilized by 1% triton, but AGO7 is still in the pellet after 1% triton treatment. This suggests to me that instead of being membrane associated, AGO7 is associated with large, non-membrane structures such as the cytoskeleton.
> We would like to thank the reviewer for his/her insightful comment. We have carefully re-evaluated the protocol used in the solubilization experiments and realized that in the conditions originally used the Triton-to-protein ratio was too small to ensure proper action of the detergent. Indeed, in particular for non-ionic detergent such as Triton, the ratio of detergent to protein is more important than absolute detergent concentration (Hetenlus A & Simons K. Solubilization of membranes by detergents. Biochim. Biophys. Acta 415: 1975) . We repeated these experiments but this time increasing the triton-to-protein ratio by diluting the proteins before treatment. In these conditions, treatment of the microsomal fraction with 1% Triton X-100 resolubilized partially AGO7. We have updated the Figure 4C to include this result and introduced the appropriate changes in the method section. This result combined with our observation that, on a continuous sucrose gradient, AGO7 equilibrates at densities comparable to the ones of a ER-marker ( Figure 4E ) further suggests the linkage of AGO7 with a membrane fraction. However, and as rightfully pointed by the reviewer, in the conditions we used, a small fraction of the cytoskeleton associated with membranes and polysomes can be retrieved (see S.
Abe, E. Davies, Journal of experimental botany 45, 253 (1994) ). Therefore we cannot formally exclude that the cytoskeleton plays a role in the association of AGO7 with membranes. To reflect this, we discuss that the association of AGO7 with the membranes could be mediated by interaction with partners.
Another point related to this assay is that they did not provide details regarding how much material from S100 and P100 was used in the western blot. As we know, the volume of S100 would far exceed that of P100. Without knowing the relative amounts of material used in the western, it is hard for the reader to judge how much enrichment there is in the P100 fraction.
> We are grateful to the reviewer for pointing out this important technical point we omitted to specify. The amount of protein in the S100 and P100 was quantified (using a detergent-compatible BCA kit -BioRad) and equal amounts (75µg) of each fraction loaded on gel for analysis. Therefore, the difference in signal intensity in S100 and P100 reflects the relative abundance of the protein in each fraction. The methods and the figure legends have been modified to consider this point. Figure 5 claims that miR390 and tasiR-ARFs co-fractionate with AGO7, but only data on miR390 were shown.
The title of
Additional Correspondence 16 January 2012
Thank you for submitting your revised manuscript. I asked referee #2 to look at the revised version and have now received the comments back. As you can see below, the referee appreciates the introduced changes and support publication in the EMBO Journal. I am therefore pleased to proceed with the acceptance of the paper for publication here.
A few editorial notes:
Referee #2 suggests a different title. I will leave it up to you if you would like to change the title. Just let me know what you would like to do.
Also, we now encourage the publication of source data, particularly for electrophoretic gels and blots, with the aim of making primary data more accessible and transparent to the reader. Would you be willing to a PDF file (per figure) comprising the original, uncropped and unprocessed scans of all or key gels used in the figures? These should be labeled with the appropriate figure/panel number, and should have molecular weight markers; further annotation could be useful but is not essential. The files will be published online with the article as a supplementary "Source Data" file. If you have any questions regarding this just contact me.
Thank you for submitting your interesting study to the EMBO Journal
Yours sincerely Editor
The EMBO Journal REFEREE REPORTS Referee #2
The technical issues that were brought up by me in the first round of review have all been addressed. I am convinced that AGO7 accumulates in membrane-associated bodies. The authors also acknowledged my disagreement with the previous title, which claimed that the membrane association was important for the ta-siRNA biogenesis function of AGO7, for which they did not provide any evidence. They changed the title to be "Cytoplasmic Arabidopsis AGO7 accumulates in membraneassociated siRNA bodies and is required for ta-siRNA biogenesis". I suggest that the title be changed to "Cytoplasmic Arabidopsis AGO7 accumulates in membraneassociated siRNA bodies", since the "is required for ta-siRNA biogenesis" part is already known from other people's studies. Alternatively, the title can be "Arabidopsis AGO7, which is required for ta-siRNA biogenesis, accumulates in cytoplasmic membrane-associated siRNA bodies".
